Baxter International | BAX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 55.76M 9.14M 2026-03
AtriCure USD 146.16M 21.26M 2026-03
Avanos Medical USD 65.6M 24.2M 2026-03
Baxter International USD 2.02B 51M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Cooper Companies USD 124.9M 14.3M 2025-12
Dexcom USD 1.12B 200.5M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
Fresenius EUR 1.31B 81M 2025-12
Globus Medical USD 560.95M 34.79M 2026-03
Halozyme Therapeutics USD 309.75M 175.93M 2026-03
ICU Medical USD 307.96M 8.23M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 480.4M 235.7M 2026-03
Integra LifeSciences USD 236.81M 1.76M 2026-03
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 488.08M 41.68M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teleflex USD 309.41M 69.15M 2026-03
Terumo JPY 217.16B 12.86B 2025-09
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03